Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Krystal Biotech Inc (NASDAQ: KRYS) closed the day trading at $139.47 down -14.06% from the previous closing price of $162.29. In other words, the price has decreased by -$14.06 from its previous closing price. On the day, 1.32 million shares were traded.
Ratios:
For a better understanding of KRYS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 33.82. For the most recent quarter (mrq), Quick Ratio is recorded 7.02 and its Current Ratio is at 7.28. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 05, 2025, initiated with a Buy rating and assigned the stock a target price of $245.
On August 06, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $195 to $204.
On November 20, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $160.Goldman initiated its Buy rating on November 20, 2023, with a $160 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 13 ’25 when Krishnan Suma sold 25,000 shares for $177.79 per share. The transaction valued at 4,444,763 led to the insider holds 1,533,056 shares of the business.
Krishnan Suma sold 25,000 shares of KRYS for $4,444,761 on Mar 13 ’25. The President, R&D now owns 1,463,711 shares after completing the transaction at $177.79 per share. On Mar 13 ’25, another insider, Krishnan Krish S, who serves as the President and CEO of the company, sold 25,000 shares for $177.79 each. As a result, the insider received 4,444,763 and left with 1,533,056 shares of the company.
Valuation Measures:
As of this moment, Krystal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.68, and their Forward P/E ratio for the next fiscal year is 14.99. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.74. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.87 while its Price-to-Book (P/B) ratio in mrq is 4.24.
Stock Price History:
Over the past 52 weeks, KRYS has reached a high of $219.34, while it has fallen to a 52-week low of $141.72. The 50-Day Moving Average of the stock is -20.15%, while the 200-Day Moving Average is calculated to be -21.27%.
Shares Statistics:
A total of 28.79M shares are outstanding, with a floating share count of 24.70M. Insiders hold about 14.53% of the company’s shares, while institutions hold 91.98% stake in the company.
